New PET tracer may spot hard-to-find breast cancer spread
NCT ID NCT05931302
First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study tests whether a newer PET scan tracer (68Ga-FAPI-46) is better than the standard one (18F-FDG) at finding how far lobular breast cancer has spread. About 40 adults with untreated lobular breast cancer will get both scans, and doctors will compare how many tumor spots each scan finds. The goal is to improve initial staging so treatment can be more accurate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOBULAR BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Princesse Grace
Monaco, 98000, Monaco
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a scan replace surgery for breast cancer staging?
- Scientists investigate rare breast cancer subtype to improve future care
- New tests could predict if breast cancer therapy is working
- New registry hopes to unlock secrets of rare breast cancer
- Can Pre-Surgery hormone therapy help lobular breast cancer patients?
- New scan may better detect Hard-to-Find breast cancer spread